BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33175580)

  • 1. Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study.
    Azhari N; Hu H; O'Malley KY; Blocker ME; Levin FR; Dakwar E
    Am J Drug Alcohol Abuse; 2021 Jan; 47(1):92-97. PubMed ID: 33175580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial.
    Dakwar E; Nunes EV; Hart CL; Foltin RW; Mathew SJ; Carpenter KM; Choi CJJ; Basaraba CN; Pavlicova M; Levin FR
    Am J Psychiatry; 2019 Nov; 176(11):923-930. PubMed ID: 31230464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial.
    Dakwar E; Levin F; Hart CL; Basaraba C; Choi J; Pavlicova M; Nunes EV
    Am J Psychiatry; 2020 Feb; 177(2):125-133. PubMed ID: 31786934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cannabis-induced disorders].
    Soyka M; Preuss U; Hoch E
    Nervenarzt; 2017 Mar; 88(3):311-325. PubMed ID: 28236096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Web-Based Self-Help Intervention With and Without Chat Counseling to Reduce Cannabis Use in Problematic Cannabis Users: Three-Arm Randomized Controlled Trial.
    Schaub MP; Wenger A; Berg O; Beck T; Stark L; Buehler E; Haug S
    J Med Internet Res; 2015 Oct; 17(10):e232. PubMed ID: 26462848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased drinking in adults with co-occurring cannabis and alcohol use disorders in a treatment trial for marijuana dependence: Evidence of a secondary benefit?
    Dunn HK; Litt MD
    Addict Behav; 2019 Dec; 99():106051. PubMed ID: 31487577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder.
    Grabski M; McAndrew A; Lawn W; Marsh B; Raymen L; Stevens T; Hardy L; Warren F; Bloomfield M; Borissova A; Maschauer E; Broomby R; Price R; Coathup R; Gilhooly D; Palmer E; Gordon-Williams R; Hill R; Harris J; Mollaahmetoglu OM; Curran HV; Brandner B; Lingford-Hughes A; Morgan CJA
    Am J Psychiatry; 2022 Feb; 179(2):152-162. PubMed ID: 35012326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual mindfulness-based psychotherapy for cannabis or cocaine dependence: a pilot feasibility trial.
    Dakwar E; Levin FR
    Am J Addict; 2013; 22(6):521-6. PubMed ID: 24131158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
    Feder A; Costi S; Rutter SB; Collins AB; Govindarajulu U; Jha MK; Horn SR; Kautz M; Corniquel M; Collins KA; Bevilacqua L; Glasgow AM; Brallier J; Pietrzak RH; Murrough JW; Charney DS
    Am J Psychiatry; 2021 Feb; 178(2):193-202. PubMed ID: 33397139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review.
    Lees R; Hines LA; D'Souza DC; Stothart G; Di Forti M; Hoch E; Freeman TP
    Psychol Med; 2021 Feb; 51(3):353-364. PubMed ID: 33536109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes from a computer-assisted intervention simultaneously targeting cannabis and tobacco use.
    Lee DC; Budney AJ; Brunette MF; Hughes JR; Etter JF; Stanger C
    Drug Alcohol Depend; 2015 Oct; 155():134-40. PubMed ID: 26307942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
    Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach bias modification for cannabis use disorder: A proof-of-principle study.
    Sherman BJ; Baker NL; Squeglia LM; McRae-Clark AL
    J Subst Abuse Treat; 2018 Apr; 87():16-22. PubMed ID: 29471922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study.
    Miranda R; Treloar H; Blanchard A; Justus A; Monti PM; Chun T; Swift R; Tidey JW; Gwaltney CJ
    Addict Biol; 2017 May; 22(3):779-790. PubMed ID: 26752416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
    Feder A; Parides MK; Murrough JW; Perez AM; Morgan JE; Saxena S; Kirkwood K; Aan Het Rot M; Lapidus KA; Wan LB; Iosifescu D; Charney DS
    JAMA Psychiatry; 2014 Jun; 71(6):681-8. PubMed ID: 24740528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.
    Anderson IM; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Elwell C; Hayden K; Holland F; Karim S; Loo C; Lowe J; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; McAllister-Williams RH;
    Lancet Psychiatry; 2017 May; 4(5):365-377. PubMed ID: 28359862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the Efficacy of Mindfulness-Based Relapse Prevention Versus Relapse Prevention for Alcohol Use Disorder: A Randomized Control Trial.
    Skrzynski CJ; Karoly H; Ellingson JM; Hagerty SL; Bryan AD; Hutchison KE
    J Stud Alcohol Drugs; 2023 Jul; 84(4):560-569. PubMed ID: 36971735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CANDIS treatment program for cannabis use disorders: findings from a randomized multi-site translational trial.
    Hoch E; Bühringer G; Pixa A; Dittmer K; Henker J; Seifert A; Wittchen HU
    Drug Alcohol Depend; 2014 Jan; 134():185-193. PubMed ID: 24176199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
    Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH
    Am J Psychiatry; 2021 Apr; 178(4):352-362. PubMed ID: 33653121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.